Research Areas
In this section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 1714 | (R)-(+)-SLV 319 | Inactive enantiomer of SLV 319 | €95.00 | |
| 1235 | Abnormal cannabidiol | Cannabinoid agonist | €135.00 | |
| 1218 | AM 251 | CB1 antagonist | €95.00 | |
| 1219 | AM 281 | CB1 antagonist | €95.00 | |
| 2791 | AM 4113 | CB1 antagonist | €105.00 | |
| 2541 | APD 597 | Orally bioavailable selective GPR119 agonist | €125.00 | |
| 2380 | APD 668 | Potent and selective, orally active GPR119 agonist | €125.00 | |
| 1572 | AR 231453 | Cannabinoid GPR119 agonist | €80.00 | |
| 3430 | AS1269574 | Selective and orally available GPR119 agonist | €90.00 | |
| 1234 | Cannabidiol | GPR55 antagonist | €105.00 | |
| 3955 | CB2R PAM C2 | First synthetic, potent and orally active CB2 receptor PAM | €120.00 | |
| 2015 | CP 945598 | CB1 antagonist | €135.00 | |
| 2119 | CP 945598 hydrochloride | CB1 antagonist | €135.00 | |
| 3097 | DBPR211 | Potent and selective peripherally restricted CB1 antagonist/inverse agonist | €125.00 | |
| 3632 | Genistein | CB1 antagonist | €70.00 | |
| 1925 | GW 842166X | Cannabinoid CB2 receptor agonist | €110.00 | |
| 1440 | HU 308 | CB2 agonist | €140.00 | |
| 1574 | Iodopravadoline | CB2 antagonist | €75.00 | |
| 1418 | JWH 133 | CB2 agonist | €110.00 | |
| 2092 | MBX 2982 | Potent and selective GPR119 agonist | €125.00 | |
| 1550 | MK 0364 | CB1 antagonist/inverse agonist | €95.00 | |
| 3028 | ML184 | Potent and selective GPR55 agonist | €120.00 | |
| 4125 | ML193 | Highly potent and selective GPR55 antagonist | €90.00 | |
| 1211 | Palmitoylethanolamide | Endocannabinoid; GPR55 agonist | €75.00 | |
| 1565 | PSNCBAM 1 | CB1 antagonist (allosteric) | €85.00 | |
| 1712 | rac-(±)-SLV 319 | Racemate of CB1 antagonist Ibipinabant (Axon 1713) | €110.00 | |
| 1713 | SLV 319 | CB1 antagonist | €105.00 | |
| 1220 | SR 141716 hydrochloride | CB1 antagonist | €70.00 | |
| 1924 | SR 144528 | CB2 receptor antagonist and/or an inverse agonist | €95.00 | |
| 2543 | ZCZ 011 | Brain penetrant CB1 positive allosteric modulator (PAM) | €90.00 | |